Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alkyl Boron. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt catalyst enables asymmetric hydroboration of mixed olefins. Delivers high enantioselectivity and substantial cost reduction in pharmaceutical intermediates manufacturing.
Patent CN120795005A enables high-purity chiral alkyl boron synthesis using cobalt catalysts. Delivers significant cost reduction and supply chain reliability for pharmaceutical intermediates.